Poland – Antineoplastic agents – Dostawa produktu leczniczego Pembrolizumab rozliczanego z programu lekowego B.6.
openInstytut Gruźlicy i Chorób Płuc · 5250008838
Value
unstated
Published
12 Nov 2026
Deadline
15 Dec 2026, 09:00 GMT · 33d left · as published, verify on the notice
Type
opportunity
33652100 · Medical equipment, pharmaceuticals & personal carePL911
Description
Przedmiotem zamówienia jest dostawa produktu leczniczego Pembrolizumab, koncentrat do sporządzania roztworu do infuzji, 25mg/ ml; op x 1 fiol. a 4 ml, op. 4090
Key facts
- Procedure
- open
- Submit via
- https://igichp.ezamawiajacy.pl
- Contact
- m.jaroszewska@igichp.edu.pl
- Bids opened
- 15 Dec 2026, 09:15 GMT
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 789313-2026
- First seen
- 12 Nov 2026
- Last updated
- 12 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/7d7cec30-1a2c-472f-a446-f1909d318e3eThe source notice is authoritative — verify deadlines and documents there before bidding.